会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • TEAR SHAPING FOR REFRACTIVE CORRECTION
    • 用于折射校正的形状
    • WO2016144483A1
    • 2016-09-15
    • PCT/US2016/017792
    • 2016-02-12
    • THOMPSON, Vance, M.
    • THOMPSON, Vance, M.
    • G02C7/04A61F9/00
    • G02C7/047
    • A lens for refractive tear shaping, having a curved lens body with a peripheral edge and a central opening therein. The central opening is shaped and sized and has a tear shaping edge structured to form a tear meniscus within the central opening. The tear meniscus being formed by interaction of a tear film of the eye and the tear shaping edge and having a posterior curvature conforming to an anterior corneal curvature and an anterior curvature. The anterior curvature is dependent on the size and shape of the central opening and structure of the tear shaping edge.
    • 一种用于折射成形的透镜,其具有带有周边边缘的弯曲透镜体和其中的中心开口。 中心开口的形状和尺寸并且具有构造成在中心开口内形成泪液弯液面的泪液成形边缘。 泪液弯月面由眼睛的泪膜与泪液成形边缘的相互作用形成,具有与前角膜曲率和前曲率相符的后曲率。 前曲率取决于中心开口的尺寸和形状以及撕裂成形边缘的结构。
    • 6. 发明申请
    • SYSTEM AND METHOD FOR POSITIONING AN EYE THERAPY DEVICE
    • 用于定位眼睛治疗装置的系统和方法
    • WO2009094468A1
    • 2009-07-30
    • PCT/US2009/031716
    • 2009-01-22
    • AVEDRO, INC.MULLER, DavidTHOMPSON, Vance
    • MULLER, DavidTHOMPSON, Vance
    • A61B18/18
    • A61B18/14A61B90/11A61B2017/306A61F9/0079A61F9/008A61F9/009A61F9/013A61F2009/00853A61F2009/00872
    • A system for aligning an eye therapy instrument over a selected area or feature of an eye provides an attachment element that is removably attached to a surface of an eye. A receiving element is coupled to the attachment element and movable relative to the attachment element. The receiving element includes a coupling element configured to operably couple an eye therapy instrument to the receiving element and adjustably move the eye therapy instrument into a selected position with respect to the attachment element. The system makes adjustments to ensure accurate delivery of treatment from the eye therapy device to areas of the eye. In one embodiment, the receiving element allows lateral adjustments to be made along one or more axes. Additionally or alternatively, the receiving element allows angular or rotational adjustments to be made about one or more axes.
    • 用于将眼部治疗仪器对准眼睛的选定区域或特征的系统提供可拆卸地附接到眼睛表面的附接元件。 接收元件联接到附接元件并且可相对于附接元件移动。 接收元件包括耦合元件,其被配置为可操作地将眼部治疗器械耦合到接收元件并且可调节地将眼部治疗仪器相对于附接元件移动到选定位置。 系统进行调整,以确保从眼部治疗装置到眼睛区域的准确传送。 在一个实施例中,接收元件允许沿着一个或多个轴进行横向调整。 附加地或替代地,接收元件允许围绕一个或多个轴进行角度或旋转调节。
    • 7. 发明申请
    • COMPOSITION AND METHOD FOR STABILIZING CORNEAL TISSUE AFTER REFRACTIVE SURGERY
    • 用于稳定手术后的角膜组织的组合物和方法
    • WO2007120457A2
    • 2007-10-25
    • PCT/US2007/008049
    • 2007-04-03
    • EUCLID SYSTEMS CORPORATIONDEWOOLFSON, BruceDEVORE, DaleTHOMPSON, Vance
    • DEWOOLFSON, BruceDEVORE, DaleTHOMPSON, Vance
    • A61K38/39
    • A61K38/39A61K9/0048A61K38/1709A61K38/45C07K14/4725
    • Methods of stabilizing collagen fibrils in a cornea comprising administering a composition comprising a protein that crosslinks collagen fibrils and a pharmaceutically acceptable carrier are disclosed. Patients that would benefit from the practice of the methods include patients' having a refractive surgical procedure, patients with keratectasia, and patients with keratodconus. In some embodiments, a protein that crosslinks collagen fibrils by binding to each of two different fibrils to form a bridge there between is use in the method. An example of a protein of this type is decorin. In other embodiments, a protein that crosslinks collagen fibrils by catalyzing the formation of a covalent bond between an amino acid in one collagen fibril and an amino acid in a second collagen fibril is used. Proteins that catalyze formation of covalent bonds between collagen fibrils include transglutaminase.
    • 稳定胶原纤维在角膜中的方法包括施用包含交联胶原纤维的蛋白质和药学上可接受的载体的组合物。 从方法实践中受益的患者包括患有屈光外科手术的患者,角膜结膜炎患者和角化角膜瘤患者。 在一些实施方案中,通过与两种不同的原纤维中的每一种结合以在其间形成桥梁来交联胶原原纤维的蛋白质在该方法中使用。 这种蛋白质的一个例子是核心蛋白聚糖。 在其它实施方案中,使用通过催化在一个胶原原纤维中的氨基酸与第二胶原原纤维中的氨基酸之间形成共价键来交联胶原纤维的蛋白质。 催化胶原纤维之间共价键形成的蛋白质包括转谷氨酰胺酶。
    • 9. 发明申请
    • CONJUNCTIVAL COVER AND METHODS THEREFOR
    • 连接罩及其方法
    • WO2015066616A1
    • 2015-05-07
    • PCT/US2014/063696
    • 2014-11-03
    • THOMPSON, Vance, M.
    • THOMPSON, Vance, M.
    • A61F9/00G02C7/04A61F2/14
    • A61F2/1451A61F9/0017G02C7/04
    • A conjunctival cover including an annular generally curved shell having a conjunctival portion structured to conform to and overly at least part of the conjunctiva of an eye. The annular generally partially spherical shell defines a generally central opening. The central opening is sized to leave a cornea of the eye substantially or partially uncovered when the conjunctival cover is applied to the eye. The conjunctival cover may include drug diffusion qualities. The conjunctival cover may include electronic components embedded therein or thereon including a sensor and an antenna in communication with the sensor and structured to transmit information to a remotely located receiver, transceiver or transponder.
    • 一种结膜盖,其包括环形的大致弯曲的壳体,其具有构造成符合眼睛结膜和至少部分眼结膜的结膜部分。 环形的大致部分球形的外壳限定了大致中央的开口。 当结膜覆盖物施加到眼睛上时,中心开口的尺寸设置成使眼睛的角膜基本上或部分地未被覆盖。 结膜覆盖物可以包括药物扩散性质。 结膜罩可以包括嵌入其中或其上的电子部件,包括与传感器通信的传感器和天线,并被构造成将信息传输到位于远程的接收器,收发器或应答器。
    • 10. 发明申请
    • SYSTEMS AND METHODS FOR RESHAPING AN EYE FEATURE
    • 用于修复眼睛特征的系统和方法
    • WO2012162529A1
    • 2012-11-29
    • PCT/US2012/039391
    • 2012-05-24
    • AVEDRO, INC.MULLER, DavidTHOMPSON, Vance
    • MULLER, DavidTHOMPSON, Vance
    • A61F9/008A61F9/01A61F9/007
    • A61F9/013A61F9/00804A61F9/00836A61F2009/00853A61F2009/00872
    • Systems and methods include a cutting instrument that creates incisions in selected areas of the cornea; an eye therapy system that applies reshaping forces to the cornea; and a controller that determines the selected areas of the cornea for the incisions and the reshaping forces from the eye therapy system, such that the reshaping forces and the incisions combine to achieve corrective reshaping of the cornea. Other systems and methods include measuring an eye to determine a required amount of reshaping of a cornea; determining one or more doses of cross-linking agent and one or more corresponding doses of photoactivating light according to the required amount of reshaping; applying the cross-linking agent to the cornea; and delivering, from a light source, the photoactivating light to the area of the eye, the photoactivating light combining with the cross-linking agent to induce the corrective reshaping of the cornea.
    • 系统和方法包括在角膜的选定区域中产生切口的切割工具; 将矫正力应用于角膜的眼科治疗系统; 以及控制器,其确定角膜的选择区域用于切口和来自眼睛治疗系统的重塑力,使得重塑力和切口相结合以实现角膜的矫正重塑。 其他系统和方法包括测量眼睛以确定角膜重塑所需的量; 根据所需的重塑量确定一个或多个剂量的交联剂和一个或多个相应剂量的光活化光; 将交联剂施用于角膜; 以及从光源将光活化光输送到眼睛的区域,所述光活化光与交联剂结合以引起角膜的矫正重塑。